Search results
Results from the WOW.Com Content Network
These side effects are usually mild and transient. Some individuals may experience throat irritation or coughing when using Fluticasone furoate inhalers. Rinsing the mouth and throat with water after inhalation can help reduce these symptoms. Headache is another common side effect reported with the use of Fluticasone furoate nasal spray or ...
Decongestant nasal sprays are advised for short-term use only, preferably 5 to 7 days at maximum. Some doctors advise to use them 3 days at maximum. A recent clinical trial has shown that a corticosteroid nasal spray may be useful in reversing this condition. [3] Topical nasal decongestants include: Oxymetazoline; Phenylephrine; Xylometazoline
Side effects. Topical decongestants should not be used for longer than a week as prolonged use may result in rhinitis medicamentosa (rebound nasal congestion). [13] Common side effects for oral decongestants include insomnia, hypertension (elevated blood pressure), and difficulty in urination. [12]
If a patient attempts to use a nasal spray treatment while they have allergic rhinitis (i.e., a runny nose), that thick mucus can make it difficult for the medication in a nasal spray to penetrate ...
[3] [8] The nasal spray is used for prevention and treatment of allergic rhinitis. [2] Nasal drops are used in the treatment of nasal polyps. The nasal spray can also be used in the mouth for mouth ulcers. [11] Fluticasone propionate in a topical form can be used to treat skin conditions such as eczema, psoriasis, and rashes. [17] [18]
Common side effects of nasal spray may include headache, dry nose, dry mouth or throat, nasal or throat irritation, nosebleeds, bad taste in mouth, nausea, dizziness, or constipation. [7] Potentially serious side effects are unusual, but include severe allergic reaction, eye pain or change in vision, or urinary retention.
For premium support please call: 800-290-4726 more ways to reach us
Researchers have tested a nasal spray aiming to fight toxic protein accumulations in the brains of mouse models of Alzheimer's disease. Their findings so far show promise.